Focus on Managed Care Pharmacy

(EDU-M2) Patient-Centric Value Frameworks: Evolving from an Economic to a Holistic Evaluation

Wednesday, October 12, 2022

1:00 PM – 2:15 PM ET

Location: Potomac A

ACPE UAN:0233-0000-22-035-L04-P | Contact Hours: 1.25 | Activity Type: Knowledge-based

Faculty(s)

Sarah Alwardt, MEng, PhD

SVP, Advisory Services
Avalere Health
Washington, DC
Shelby Harrington, MS, RN

Principal, Quality and Clinical Strategy
Avalere Health
Washington, DC

Moderator(s)

WB

Wendy Boyles, PharmD

Clinical Director, Health Plan Division
Express Scripts
San Diego, California

Researchers, payers, regulators, managed care organizations, and other stakeholders typically use traditional value frameworks that focus on economic and quantifiable clinical endpoints to evaluate the impact of a disease and the value of its treatments. However, these frameworks may not account for the full spectrum of ways in which a condition impacts patients’ lives or their preference for treatment.

New patient-centric frameworks are being integrated into stakeholder operations so that a more comprehensive and nuanced perspective on disease impact and treatment value can be factored into value-based decisions. Though there are challenges with scaling the use of these new frameworks, innovations in patient care models and health care technology are providing viable solutions.

This session will discuss the evolution to patient-centric value frameworks, their utility to different stakeholders, and how they can be used as a mechanism to drive the transformation to a patient-centered, equitable health system.

Learning Objectives:

At the completion of this activity, participants should be able to:

Explain the differences between traditional value frameworks and patient-centric value frameworks.
Describe challenges in data collection, measurement, and evaluation of treatments using patient-centric value frameworks and some potential solutions.
Describe how technology and advances in models of care delivery can overcome these data challenges.
Discuss how each stakeholder in the treatment value chain (i.e., patients, providers, pharmacy benefit managers, payers, regulatory bodies, legislators) have a role to play in embedding patient-centric value frameworks into practice.